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Air Travel and the Spread of Inﬂ  uenza: 
Important Caveats
Cécile Viboud, Mark A. Miller, Bryan T. Grenfell, Ottar 
N. Bjørnstad, Lone Simonsen
While air travel contributes to the spread of inﬂ  uenza 
epidemics, the magnitude of impact is not clear compared to 
other factors—a crucial issue when considering a ﬂ  ight ban in 
the context of pandemic planning. Recent modeling efforts 
simulating the spread of pandemic inﬂ  uenza have concluded 
that such an intervention would matter little relative to 
other interventions [1–3]. But this assessment has now been 
challenged by an observational study of inﬂ  uenza in the 
winter following the post-9/11/2001 depression in air trafﬁ  c. 
Brownstein and colleagues’ study published in the September 
issue of PLoS Medicine [4] correlates variations in air trafﬁ  c 
volume with patterns of timing and spread in inﬂ  uenza 
epidemics, based on United States mortality data from nine 
epidemic seasons between 1996 and 2005. While we ﬁ  nd the 
study interesting, we have identiﬁ  ed several important caveats 
and question the robustness of the conclusions.
The core of this study’s results lies in the observation that 
the 2001–2002 inﬂ  uenza epidemic immediately following 
9/11 was late in the season and peaked in March (week of 
year 11), whereas the eight surrounding epidemics peaked 
between the end of December and the end of February (week 
of year 52 to 9). The authors attribute this delay to the 27% 
decline in air trafﬁ  c that followed 9/11.
Given the complexities of inﬂ  uenza virus subtype cycling 
and antigenic drift [5,6], it is essential to consider longer-
term disease data spanning much more than nine years to 
interpret the “lateness” of the 2001–2002 epidemic. Using 
US national vital statistics data covering 30 winters from 
1972 to 2002 [5], we identiﬁ  ed four epidemics peaking 
in the month of March (13%), including the 2001–2002 
epidemic following 9/11, but also two epidemics in the 
1970s and the more recent 1991–1992 epidemic (Figure 1A). 
Furthermore, the average timing of inﬂ  uenza epidemics has 
not changed between 1972 and 2002—despite a concurrent 
and steady increase in air trafﬁ  c volume by over 300% 
(Figure 1A) [7]. Indeed, during the earlier part of the last 
century when air trafﬁ  c was minimal, inﬂ  uenza epidemics 
rapidly circulated around the world. Moreover, real-time 
inﬂ  uenza virus surveillance data from the US Centers for 
Disease Control and Prevention [8] show that last winter’s 
(2005–2006) epidemic was even more delayed than the 
epidemic following 9/11, despite a 20% increase in air 
passenger trafﬁ  c compared to the situation before 9/11 [7]. 
Clearly, late-season inﬂ  uenza epidemics have occurred and 
are still occurring even in the absence of restrictions on air 
travel. Hence a longer time perspective, with observations 
from both prior and more recent data, challenges this study’s 
conclusions.
In addition to comparing the timing of inﬂ  uenza epidemics 
across different seasons, Brownstein et al. analyzed the 
rate of disease spread among US administrative regions for 
their nine seasons of interest (1996–2005). In our previous 
work, we estimated the rate of inﬂ  uenza spread among all 
US states for 30 consecutive seasons (1972–2002) [5]. Our 
analysis shows that the epidemic following 9/11 spread at 
a rate comparable to other epidemics (Figure 1B), even 
after adjusting for the subtype of circulating viruses [5]. To 
increase our understanding of the spread of inﬂ  uenza, it 
is essential to quantify the relative importance of different 
modes of transportation. As an example, our recent study 
considered multiple modes of transportation (including 
air travel) and identiﬁ  ed travel to and from work as a key 
determinant of the regional spread of epidemics [5]. 
In conclusion, Brownstein and colleagues’ analysis of the 
“natural experiment” of the post-9/11 season is innovative 
and ingenious—but in and of itself could not demonstrate 
a robust association or a causal link between the decrease in 
air trafﬁ  c and delayed timing of inﬂ  uenza epidemics. Even 
if there in fact had been a delay as hypothesized, the study 
lacked power to address the hypothesis, because this single 
“natural experiment” was set in a background of considerable 
variability in inﬂ  uenza epidemic patterns. Extrapolations 
from the study’s ﬁ  ndings predict that a ﬂ  ight ban could 
delay a pandemic by two months [9]—but we have shown 
here that this prediction is not supported by the analysis of 
more extensive disease data and transportation statistics. It 
is also unclear how a “natural experiment” conducted in the 
inter-pandemic period is applicable to a pandemic situation, 
where novel inﬂ  uenza viruses have higher transmissibility 
and circulate in fully susceptible populations, and may cause 
different age-patterns of transmission [10]. While Brownstein 
and colleagues’ study represents an intriguing starting point, 
this study alone does not provide the critical quantitative 
evidence needed to evaluate the impact of travel restrictions 
on future pandemics.  
Cécile Viboud (viboudc@mail.nih.gov)
doi:10.1371/journal.pmed.0030503.g001
Figure 1. Patterns of Timing (A) and Spread (B) of 30 Inﬂ  uenza 
Epidemics in the US, Together with Trends in Air Travel Statistics 
Inﬂ  uenza patterns are based on weekly national vital statistics from 
1972 to 2002 [5]. Air travel statistics represent the annual number of 
domestic and international passengers on US air carriers (scheduled 
ﬂ  ights, secondary y-axis) [7]. (A) Time series of timing of national peaks 
of inﬂ  uenza mortality. The 2001–2002 epidemic following 9/11 peaked 
in March, and so did two epidemics in the 1970s and one in the 1990s. 
(B) Time series of rate of spread between US states. The rate of spread of 
the 2001–2002 epidemic following 9/11 is comparable to that of other 
epidemics. Rate of spread as calculated in [5], based on the timing of 
epidemic peaks in each state. PLoS Medicine  |  www.plosmedicine.org 2160
Mark A. Miller
Fogarty International Center, National Institutes of Health
Bethesda, Maryland, United States of America
Bryan T. Grenfell 
Ottar N. Bjørnstad 
Center for Infectious Diseases Dynamics, Pennsylvania State University 
University Park, Pennsylvania, United States of America
Fogarty International Center, National Institutes of Health
Bethesda, Maryland, United States of America
Lone Simonsen 
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Bethesda, Maryland, United States of America
References
1.  Cooper BS, Pitman RJ, Edmunds WJ, Gay NJ (2006) Delaying the 
international spread of pandemic inﬂ  uenza. PLoS Med 3: e212. 
doi:10.1371/journal.pmed.0030212
2.  Ferguson NM, Cummings DA, Fraser C, Cajka JC, Cooley PC, et al. (2006) 
Strategies for mitigating an inﬂ  uenza pandemic. Nature 442: 448–452.
3. Germann TC, Kadau K, Longini IM Jr, Macken CA (2006) Mitigation 
strategies for pandemic inﬂ  uenza in the United States. Proc Natl Acad Sci U 
S A 103: 5935–5940.
4.  Brownstein JS, Wolfe CJ, Mandl KD (2006) Empirical evidence for the effect 
of airline travel on inter-regional inﬂ  uenza spread in the United States. 
PLoS Med 3: e401. doi:10.1371/journal.pmed.0030401
5.  Viboud C, Bjornstad ON, Smith DL, Simonsen L, Miller MA, et al. (2006) 
Synchrony, waves, and spatial hierarchies in the spread of inﬂ  uenza. Science 
312: 447–451.
6.  Smith DJ, Lapedes AS, de Jong JC, Bestebroer TM, Rimmelzwaan GF, et 
al. (2004) Mapping the antigenic and genetic evolution of inﬂ  uenza virus. 
Science 305: 371–376.
7.  Bureau of Transportation Statistics (2006) Air carrier trafﬁ  c statistics. US 
Department of Transportation. Available: http:⁄⁄www.bts.gov/programs/
airline_information/air_carrier_trafﬁ  c_statistics. Accessed 25 October 2006.
8.  US Centers for Disease Control and Prevention (2006) Inﬂ  uenza activity in 
the US. Available: http:⁄⁄www.cdc.gov/ﬂ  u. Accessed 25 October 2006.
9.  Enserink M (2006) Ground the planes during a ﬂ  u pandemic? Studies 
disagree. Science 313: 1555.
10. Epstein SE (2006) Prior H1N1 inﬂ  uenza infection and susceptibility of 
Cleveland Family Study participants during the H2N2 pandemic of 1957: An 
experiment of nature. J Infect Dis 193: 49–53.
Citation: Viboud C, Miller MA, Grenfell BT, Bjørnstad ON, Simonsen L (2006) Air 
travel and the spread of inﬂ  uenza: Important caveats. PLoS Med 3(11): e503. 
doi:10.1371/journal.pmed.0030503
Copyright: © 2006 Viboud et al. This is an open-access article distributed under the 
terms of the Creative Commons Attribution License, which permits unrestricted 
use, distribution, and reproduction in any medium, provided the original author 
and source are credited.
Funding: The authors received no speciﬁ  c funding for this article. 
Competing Interests: The authors have declared that no competing interests exist.
Air Travel and the Spread of Inﬂ  uenza: Authors’ Reply
Viboud et al. [1] offer thoughtful commentary on our paper 
[2], opening a scientiﬁ  c exchange that we hope brings 
attention to a critical issue. We reported the ﬁ  rst empirical 
and quantitative evidence for the effect of airline travel 
on the rate of epidemic inﬂ  uenza spread. Though other 
investigators have also found this relationship [3–6], there 
is no consensus on effect size. We welcome scrutiny of our 
methods and results and believe the ﬁ  ndings stand for the 
following reasons.
Viboud et al., taking a longer historical perspective, suggest 
that the slower spread and late peaking of the 2001–2002 
season is not unique and highlight three other late seasons 
dominated by inﬂ  uenza B (1992–1993, 1973–1974, and 
1976–1977). Recent studies, including one by Viboud and 
colleagues, ﬁ  nd that B seasons have different epidemiological 
characteristics than A/H3N2 seasons, which may explain 
the late peaking in these years [7,8]. As 2001–2002 was 
dominated by inﬂ  uenza A/H3N2, late peaking in 2001–2002 
cannot be explained by dominant subtype (nor climatic 
conditions). Our study period from 1996–2005 represents the 
longest stretch of A/H3N2 seasons in over 30 years, essentially 
controlling for subtype. Viboud et al. also point to the 2005–
2006 season as particularly delayed. We examined peaking 
during that season using mortality data from the US Centers 
for Disease Control and Prevention, in order to compare to 
our estimates from prior seasons [9]. We ﬁ  nd that mortality 
as well as morbidity was bimodal, with larger peaks in January 
and December, respectively. We thus reafﬁ  rm that 2001–2002, 
being the latest peaking H3N2 season in over 30 years, is an 
aberrant season for which airline travel interruption remains 
the best explanation.
Viboud and colleagues’ letter does not take into account 
that our results are not simply based on an outlier year, 
nor are they based on a single data source. Rather, we have 
revealed an important correlation across nine inﬂ  uenza 
seasons. The impact of airline volume on ﬂ  u spread does not 
depend on the 2001–2002 season and remains signiﬁ  cant 
even after its exclusion. Since considering longer time series 
may provide insight, we repeated our methods on the 30-year 
mortality time series which Viboud et al. also analyzed [10]. 
We employed the same spatial aggregation (nine geographic 
regions) and time series methods as described in [2]. We 
doi:10.1371/journal.pmed.0030502.g001
Figure 1. Inﬂ  uence of United States Airline Volume on Inﬂ  uenza 
Spread and the Timing of Yearly Transmission over 30 Inﬂ  uenza 
Seasons
(A) The association between airline travel from September to December 
and the timing of the US inﬂ  uenza peak is displayed. Airline volume 
signiﬁ  cantly predicts the timing of seasonal inﬂ  uenza mortality (r2 = 
0.460; p < 0.001). The timing of seasonal national inﬂ  uenza mortality 
(blue dots) is estimated from cross-correlation of each season with 
the 1972–1973 season. (B) The association between airline travel 
from September to December and time to transnational US spread is 
displayed. The numbers of traveling domestic passengers signiﬁ  cantly 
predicts transnational inﬂ  uenza spread (r2 = 0.265; p = 0.004). Index 
spread of inﬂ  uenza (blue dots) is estimated from the 99% conﬁ  dence 
interval of the cross-correlation values for the nine major geographic 
regions of the United States against the national curve for a give year, as 
previously described [2].
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found substantial long-term log-linear trends toward earlier 
peaking and faster spreading inﬂ  uenza epidemics that are 
correlated with air travel volume (r2 = 0.460; p < 0.001 and 
r2 = 0.265; p = 0.004, respectively, Figure 1). Thus, our new 
analyses of longer-term data support an effect of airline travel 
volume.
We strongly caution that other factors may inﬂ  uence 
these trends, including population density, air passenger 
demographics, ground transportation, and climate. Our 
design relies on a shorter, more recent time series to avoid 
confounding by longer term secular trends that may be 
evident in the 30-year time series. Given the three year 
backlog of the 30-year dataset, the data Viboud et al. use do 
not permit the interrupted time series analysis at the core of 
our investigation.
Reconciliation of our different time series methodologies 
and datasets should be considered in future research. 
Nonetheless, because our results were conﬁ  rmed with viral 
surveillance data, we remain conﬁ  dent in the robustness of 
our analysis. We agree that other modes of transportation 
are important inﬂ  uences; our paper makes no claim that 
air travel is the only mechanism of spread, and we explicitly 
report that our model explains a portion of the variation in 
yearly inﬂ  uenza spread and peak.
Finally, Viboud et al. emphasize the limited applicability of 
our ﬁ  ndings to pandemics. We agree and have highlighted 
this limitation in our paper. The decision to restrict travel 
should be multifactorial. We do hope that it will be evidence 
based. Our analyses (including those presented here) provide 
empirical insight into the previously uncharacterized effect 
of air travel ﬂ  uctuation on inﬂ  uenza spread. They are one 
contribution to a small body of investigations that are forming 
the basis of global policy on ﬂ  u preparedness. Though 
the effect we observe might be smaller under pandemic 
conditions, the beneﬁ  t of a delay is worthy of consideration by 
scientists and policy makers where lives are at stake and even 
a short lead time may be of enormous public health value.
We are pleased that Viboud et al. have engaged in a 
discourse that we hope will strengthen the scientiﬁ  c basis of 
pandemic preparedness. We call on governments, industry, 
and health care to create a more accessible, freely available, 
and well-documented data repository for geographically and 
temporally detailed data on inﬂ  uenza [11] and encourage 
empirical analyses of the dynamics and mechanisms of 
inﬂ  uenza spread.  
John S. Brownstein (john_brownstein@harvard.edu)
Kenneth D. Mandl
Children’s Hospital Boston 
Harvard–MIT Division of Health Sciences and Technology 
Harvard Medical School
Boston, Massachusetts, United States of America
Cecily J. Wolfe
University of Hawaii at Manoa
Honolulu, Hawaii, United States of America
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Fluoxetine and Suicide Rates: 
Suicide and the Economy
Carlos A. Camargo, Daniel A. Bloch
We wish to comment on the paper by Milane et al. [1] and 
also refer to the Perspective by Baune and Hay [2] in the June 
issue of PLoS Medicine on the effect of ﬂ  uoxetine prescriptions 
on the suicide rate in the United States. Milane et al. 
examined two sets of variables: the number of prescriptions 
for ﬂ  uoxetine in the United States, and the Census Bureau 
mortality tables with the age adjusted suicide rates for the 
years 1988 to 2002. The date 1988 is chosen because in 
that year ﬂ  uoxetine was introduced in the US. The authors 
report that the Spearman correlation coefﬁ  cient between the 
two sets of variables equals -0.92 with a p-value of less than 
0.001. The less suicides, the more tablets of ﬂ  uoxetine are 
prescribed, or vice versa. The least-squares regression line is 
displayed in Figure 1.
From this simple association they build an elaborate ediﬁ  ce, 
predicting what the suicide trends would have been had 
ﬂ  uoxetine not been prescribed, and they calculate ﬁ  gures for 
“the thousands of lives saved” for both men and women...even 
though it is not known how many of these prescriptions were 
for men or for women, whether the patients took the tablets 
or not, or for how long they took the medication. In addition, 
the baseline period used to calculate the suicide trend, and 
thus to predict the future, was arbitrary: from 1960 to 1987, 
when the suicide rates had a slight gradual increase in the 
1970s. Had they used the period 1950 to 1987, a different 
“trend” would have been obtained, since the suicide rates 
decreased during the economic expansion of the 1950s [3].
It is widely known that one cannot infer causality simply 
based on statistical association. Baune and Hay pointed this 
out and wrote: “In a study like this, it is also important to 
consider other potential explanations for the fall of suicide 
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rates, such as improvements in the economy...” In this letter 
we report on the association of other variables with the 
suicide rates, for we ﬁ  nd that the most glaring defect of the 
Milane et al. article is the total absence of analysis to address 
likely confounding by many other factors.
Suicide is the ﬁ  nal outcome of many conditions, and there 
have been, for many decades, scholarly articles indicating the 
many risk factors which increase the likelihood of suicide: 
poverty, loss of employment, and several other economic 
indicators have been shown to have a strong effect upon 
suicide rates. For example, during the Great Depression 
of the 1930s the rate of suicide rose signiﬁ  cantly, and fell 
when the economy improved and unemployment decreased 
in the 1940s. On this matter, the literature is quite clear 
and the references abundant [4–8]. In the 1990s there was 
a very substantial and prolonged improvement of the US 
economy [9], which could partially explain a lowering of the 
suicide rate. We have chosen three economic indicators for 
the period from 1988 to 2002 and correlated them with the 
suicide rate, using the Spearman correlation coefﬁ  cient to 
quantify the strength of the association. The yearly data for 
the suicide rates and numbers of ﬂ  uoxetine prescriptions, 
for the three economic indicators (Dow Jones average, food 
stamp rate, and unemployment rate) and for the property 
crime and burglary rates are all contained in Table 1. The 
ﬁ  ndings are not surprising: The unemployment rate during 
those years has a strong positive correlation with the suicide 
rate: r = 0.62, p = 0.014.
The percentage of the US population eligible for the Food 
Stamp Program, a reasonable indicator of poverty rates, has a 
stronger positive correlation with the suicide rates: r = 0.84, p 
= 0.0002.
The Dow Jones industrial average for each of those years, 
when compared with the suicide rate of the US population, 
gives an even stronger (negative) correlation: r = -0.98, p < 
0.0001 (see Figure 2).
We also calculated the correlation between ﬂ  uoxetine 
prescriptions and the Dow Jones average. Not surprisingly, 
there is a very strong positive correlation: r = 0.925, p < .0001 
(see Figure 3).
We doubt that many will advance the thesis that the 
increasing sales of ﬂ  uoxetine were, somehow, one of the 
doi:10.1371/journal.pmed.0030501.g001 
Figure 1. Correlation between Suicide Rates and Fluoxetine 
Prescriptions
doi:10.1371/journal.pmed.0030501.g002
Figure 2. Correlation between Suicide Rates and the Dow Jones 
Average
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causes of the rise of the Dow Jones index. In fact, if the 
number of ﬂ  uoxetine prescriptions is correlated with any 
variable that also steadily increased, or decreased, during all 
those years (1988–2002), a statistically signiﬁ  cant association 
is most likely to be demonstrated. For example, the rate of 
crimes against property, obtained from the US Department 
of Justice, for the period 1988–2002 also exhibits a very high 
negative correlation with the ﬂ  uoxetine prescriptions: r = 
-0.99, p < 0.0001. The rate of burglaries does also: r = -0.99, 
p < 0.0001. These relationships are not causal. Most scholars 
would relate the decrease in crime rates to the improvement 
of the economy during those years, rather than to increased 
sales of ﬂ  uoxetine. The Spearman correlation coefﬁ  cients for 
all possible pair-wise comparisons are contained in Table 2.
Given these ﬁ  ndings, we decided to explore the 
relationship of suicide rates with both ﬂ  uoxetine prescriptions 
and Dow Jones averages as potentially associative factors in a 
single multivariate model. Results are displayed in Table 3. 
This allowed us to assess the association between ﬂ  uoxetine 
and suicide adjusting for the Dow Jones, an economic 
indicator. Statistically, the association is quantiﬁ  ed with a 
“partial” Spearman correlation coefﬁ  cient. With this analysis 
the ﬂ  uoxetine association was not signiﬁ  cantly correlated 
with the suicide rate: ﬂ  uoxetine had an adjusted Spearman 
correlation of -0.18 (p = 0.54) whereas the adjusted Dow Jones 
correlation remained high at -0.88 (p < 0.0001).
In conclusion, we believe that there is little likelihood that 
the increasing sales of ﬂ  uoxetine from 1988 to 2002 were 
the cause of the modest decrease in the suicide rate during 
those years. It appears more likely that factors such as those 
connected with the sustained economic recovery of the 1990s 
were responsible.  
Carlos A. Camargo (ccamargo@stanford.edu)
Daniel A. Bloch
Stanford University School of Medicine
Stanford, California, United States of America
Table 1. Raw Data by Year
Year Suicide Rate Dow Jones a Food Stamp b Unemployed c Fluoxetine 
Prescriptions a
Property Crime d Burglary d
1988 12.5 2,168 15.6 5.5 2,469 378.4 74.3
1989 12.3 2,753 5.3 6,133 373.4 67.7
1990 12.5 2,633 15.07 5.6 10,655 348.9 64.5
1991 12.3 3,168 16.25 6.8 10,120 353.7 64.6
1992 12.1 3,301 17.05 7.5 11,443 325.3 58.6
1993 12.2 3,754 17.55 6.9 12,163 318.9 58.2
1994 12.1 3,834 17.03 6.1 16,427 310.2 56.3
1995 12 5,117 13.33 5.6 18,838 290.5 49.3
1996 11.7 6,448 13 5.4 20,705 266.4 47.2
1997 11.4 7,908 11.88 4.9 22,776 248.3 44.6
1998 11.3 9,181 11.22 4.5 24,757 217.4 38.5
1999 10.7 11,497 11.56 4.2 24,742 198 34.1
2000 10.4 10,787 10.62 4 24,344 178.1 31.8
2001 10.7 10,021 11.14 4.7 29,097 166.9 28.7
2002 10.9 8,589 12.04 5.8 33,320 159 27.7
a Suicide rates and number of ﬂ  uoxetine prescriptions from [1]. Dow Jones industrial averages used are for the last day of December of each year. Available: http://ﬁ  nance.yahoo.com/q/
hp?s=%5EDJI&a=11&b=1&c=1988&d=11&e=11&f=2002&g=d&z=66&y=3234. Accessed 31 October 2006.
b Food Stamp Program rates are obtained by dividing the number of eligible individuals by the US population for each year. Figures from Food Stamp Program Operations Data and the US 
Census Bureau.
c Unemployment rates were obtained from the US Census Bureau, Statistical Abstract of the United States: 2006 (125th Edition), Washington D. C., Table 576.
d Rates for total property crime and burglary were obtained from the US Department of Justice, Bureau of Justice Statistics. Available: http://www.ojp.usdoj.gov/bjs/gvc.htm#Property. 
Accessed 31 October 2006.
doi:10.1371/journal.pmed.0030501.t001
Table 2. Spearman Correlation Coefﬁ  cients (p-Value, Sample Size)
Dow Jones Food Stamp Unemployed Property Crime Burglary Fluoxetine
Suicide Rate -0.98 (<0.001, 15) 0.84 (0.0002, 14) 0.62 (0.0145, 15) 0.95 (<0.0001, 15) 0.95 (<0.0001, 15) -0.92 (<0.0001, 15)
Dow Jones -0.83 (0.0002, 14) -0.63 (0.0108, 15) -0.94 (<0.0001, 15) -0.94 (<0.0001, 15) 0.93 (<0.0001, 15)
Food Stamp 0.92 (<0.0001, 14) 0.80 (0.0006, 14) 0.80 (0.0006, 14) -0.78 (0.0010, 14)
Unemployed 0.50 (0.0574, 15) 0.50 (0.0574, 15) -0.49 (0.0661, 15)
Property Crime 1.00 (<0.0001, 15) -0.99 (<0.0001, 15)
Burglary -0.99 (<0.0001, 15)
doi:10.1371/journal.pmed.0030501.t002
Table 3. Type III Analysis of Variance Table for Regression of 
Suicide Rate on Dow Jones Averages and Number of Fluoxetine 
Prescriptions
Source DF SS MS F-Value p-Value
Dow Jones 1 1.26 1.26 44.77 <0.0001
Fluoxetine 1 0.01 0.01 0.38 0.5481
DF, degrees of freedom; MS, mean square; SS, sum of squares
doi:10.1371/journal.pmed.0030501.t003
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Fluoxetine and Suicide Rates: Author’s Reply
Suicide is a complex outcome which cannot be attributed 
to a single factor. While we explored an association 
between suicide and antidepressant prescriptions, we fully 
acknowledge, as Camargo and Bloch suggest [1], that our 
work does not fully explain the observed trends. However, 
in other settings, the same association between increased 
antidepressant prescriptions and decreases in suicide 
have been observed. Please refer to the following article, 
published after ours came out in PLoS Medicine: “Increased 
antidepressant use and fewer suicides in Jamtland county, 
Sweden, after a primary care educational programme on the 
treatment of depression” [2]. 
I look forward to reading Camargo and Bloch’s new 
article on the association of socioeconomic factors and 
suicide rates.  
Julio Licinio (licinio@miami.edu)
University of Miami
Miami, Florida, United States of America
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Intellectual Property and Access to 
ART: Unwise Choice of Terminology
Richard Stallman
The article “How Do Intellectual Property Law and 
International Trade Agreements Affect Access to 
Antiretroviral Therapy?” is very useful for its substance, 
but due to an unwise choice of terminology, it will tend to 
mislead the public in a way that the authors and editors 
probably are not aware of, which will promote the sorts of 
abuse that it seeks to criticize. This results from the use of 
the term “intellectual property.” This article uses the terms 
“intellectual property law” and “patent law” interchangeably, 
which is like using “Asia” and “India” synonymously. However, 
most readers will recognize the latter as loose use of language, 
doi:10.1371/journal.pmed.0030501.g003
Figure 3. Correlation between Fluoxetine Prescriptions and the Dow 
Jones Average
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so they will not really be led astray. Only a few will realize 
that identifying patents with “intellectual property law” is just 
as mistaken, so real confusion will result. I ask the editors 
of PLoS Medicine, and the readers and writers of articles, to 
be on guard against confusing use of the term “intellectual 
property”—which means, nearly all use of the term. See 
http:⁄⁄www.gnu.org/philosophy/not-ipr.xhtml for more 
explanation of the problems of this term.  
Richard Stallman (rms@gnu.org)
Free Software Foundation
Boston, Massachusetts, United States of America
References
1.  Westerhaus M, Castro A (2006) How do intellectual property law and 
international trade agreements affect access to antiretroviral therapy? PLoS 
Med 3: e332. doi: 10.1371/journal.pmed.0030332
Citation: Stallman R (2006) Intellectual property and access to ART: Unwise choice 
of terminology. PLoS Med 3(11): e509. doi:10.1371/journal.pmed.0030509
Copyright: © 2006 Richard Stallman. This is an open-access article distributed 
under the terms of the Creative Commons Attribution License, which permits 
unrestricted use, distribution, and reproduction in any medium, provided the 
original author and source are credited.
Funding: The author received no speciﬁ  c funding for this article. 
Competing Interests: The author has declared that no competing interests exist.
Intellectual Property and Access to ART: Authors’ Reply
We would like to thank Richard Stallman [1] for 
emphasizing the distinction between intellectual property 
law and patent law, which was not fully elucidated in 
our article (“How Do Intellectual Property Law and 
International Trade Agreements Affect Access to 
Antiretroviral Therapy?”) [2]. However, we don’t feel that 
this distinction detracts from our overall argument that 
restrictions placed on medicines in the name of protecting 
“intellectual property” hurt efforts to expand access to 
essential medicines throughout the world. It is not so much 
the speciﬁ  c distinctions between patenting and intellectual 
property that interest us, but general acceptance of the 
principle that life-saving medicines can be “owned” and 
kept from those most afﬂ  icted by disease—often living in 
poverty—based on this concept of ownership.  
Arachu Castro (Arachu_Castro@hms.harvard.edu)
Harvard Medical School
Boston, Massachusetts, United States of America
Michael Westerhaus
Brigham and Women’s Hospital
Boston, Massachusetts, United States of America
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City Initiative: Baby Steps 
to a Better Future
Ramesh Vidavalur
The article on the new initiative for newborn health in India 
by A. Fernandez and D. Osrin [1] outlines an innovative 
approach to tackling the alarming global burden of infant 
mortality. There are currently an estimated 8 million annual 
deaths within the ﬁ  rst month of life [2], the majority of which 
are in developing countries. Dr. Fernandez rightly focuses 
on challenges and the possible innovative, yet effective, 
interventions to improve maternal and infant health.
Historically, it almost took 50 years to reduce the infant 
mortality rate in India by 50% (151 per 1,000 live births 
in 1951 to 69 per 1,000 live births in 2001), and the policy 
makers are optimistic about further decreasing it to 30 
per 1,000 live births by 2010. They also hope to reduce 
the present maternal mortality rate of 4/1,000 to 1/1,000 
by the same time [3]. As the majority of reproductive and 
childhood morbidities and mortalities can be reduced by 
primary prevention and early intervention strategies, large-
scale adaptation of community intervention strategies will 
be particularly useful in helping the next generation to have 
a head start in good health, as the expected population in 
15–59 age group will massively increase from 519 million to 
800 million by 2016 in India [4]. 
Health spending in India at 6% of gross domestic product 
is among the highest levels estimated for developing 
countries. In per capita terms, it is higher than in China, 
Indonesia, and most African countries, but lower than 
Thailand. Public spending on health in India has itself 
declined from 1.3% of gross domestic product in 1990 
to 0.9% in 1999. Individual states have cut down health 
budgets from 7.0% to 5.5%, in spite of the Bhore Committee 
(a committee on health surveys and development) 
recommendation of 15% [5]. The lack of resources, 
infrastructure, and awareness can further hinder the balance 
of health and disease and puts a considerable burden on the 
poor, rural Indian population. 
In recent years, a growing constituency of 
nongovernmental organizations have drawn attention to 
maternal and child health, supplementing government’s 
relatively recent initiative Child Survival and Safe 
Motherhood. As Fernandez et al. rightly point out regarding 
the demand and supply sides, India is not likely to be in a 
position to afford institutional care for all births even if this 
was considered a desirable goal. So the supply side should 
be strengthened through birth attendants, community 
education, microlevel organizations, and the effective 
integration of traditional and modern health-care systems. 
One of the best ways to do this is through identifying and 
strengthening nongovernmental organizations that have high 
motivation, social commitment, sensitivity to poor, ﬂ  exibility, 
and innovativeness. They can mobilize, empower, and 
increase awareness through their grassroot workers from the 
communities.
It has been proven in numerous trials that community-
based interventions such as home-based neonatal care and 
usage of birth attendants can signiﬁ  cantly reduce the infant 
mortality rate and improve maternal health [6]. 
At present, India is in the midst of an epidemiological and 
health transition wherein multiple factors like urbanization 
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and migration, changing lifestyles, and democratic 
decentralization have an enormous impact on the above 
issues. Now is the time for governments and policy makers not 
only to put feasible plans in place with short-term goals, but 
also to ensure that we have adequate human resources, strong 
community ownership, improved information dissemination 
through the media, investment in health systems research, 
and lastly,  a system that will monitor progress towards a 
healthy future.  
Ramesh Vidavalur (rvidavalur@yahoo.com)
University of Connecticut Health Center
Farmington, Connecticut, United States of America
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Conjunctival FOXP3 in Trachoma: 
T Cells Not Speciﬁ  ed
Michael Probst-Kepper
The article by Faal et al. [1] describes differences in the level 
of FOXP3 mRNA expression in the conjunctiva of patients 
with Chlamydia trachomatis infection. The authors suggest that 
their results may indicate a role for regulatory T cells in the 
resolution of conjunctival immune response, since FOXP3 
mRNA remained elevated even if clinical disease signs were 
present in the absence of infection.
But suggestions about the function of regulatory T cells in 
diseases based only on the quantiﬁ  cation of FOXP3 mRNA 
should be considered with great caution. According to the 
current state-of-the-art it is well established that FOXP3 does 
not specify human regulatory T cells since it is expressed 
at the mRNA and the protein levels to different extents 
[2–5]. Thus, without quantiﬁ  cation of FOXP3 protein at 
the single cell level in conjunction with reliable markers of 
human regulatory T cells, e.g., the recently identiﬁ  ed lack of 
CD127 expression on regulatory T cells [6,7], the potential 
contribution or association of regulatory T cells with a disease 
cannot be assessed.  
Michael Probst-Kepper (probst-kepper.michael@mh-hannover.de)
Hannover Medical School
Hannover, Germany
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Health Development versus Medical 
Relief: The Illusion of Aid 
Maria Rubio, Jose Luis Portero
Gorik Ooms sheds light on the controversial use of the 
concept of sustainability by development agencies [1]. 
International organizations involved in foreign aid and local 
governments support health policies that decrease the size, 
the potential, and the budget of the public health sector and 
hamper the access to health through fee-for-service systems. 
Under the so-called Health Sector Reform Agenda, out-of-
pocket charges make unsustainable the cost of health care for 
the poorest. Health insurance systems have a minor effect on 
the health of the poor, either because the system generates 
permanent barriers to access health care or the services are 
not really functioning. It is debatable whether a complex 
instrument, such as health insurance, can be valuable in 
societies with depleted governmental funds, rundown health 
services, and a high index of poverty and inequity. So, free 
health care is the only affordable and sustainable option for 
the poorest.
On the other hand, Médecins Sans Frontières (MSF) 
fosters the illusion of independent aid in a vast world full of 
necessities, makes irrelevant political views through the ﬂ  ag 
of neutrality, and digests the lecture of conﬂ  icts for the taste 
of the white man’s tears. MSF knows that their projects, as 
most of the projects, are not sustainable and therefore rejects 
sustainability as an argument to act. But MSF is concerned 
about sustainability as the organization calls for stronger 
national commitment and more international aid for health 
through emergency development. Behind the oratory, 
MSF assumes that the governments have the power for an 
appropriate answer.
Sustainability cannot be analyzed alone. Community 
development, grassroots democracy, social justice, human 
rights, humanitarianism, or empowerment are the conceptual 
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ideas that back the illusion of aid in the Western civil society. 
They are rhetorical terms that could even sound radical 
but, paradoxically, due to their apolitical approaches, 
make international aid and cooperation harmless for 
governments and policies that generate injustice. Moreover, 
postmodernism appeals for individual attention and 
marginalizes collective political actions that could have 
greater impact.
Solomon R. Benatar wrote in this journal that poor health 
reﬂ  ects systemic dysfunction in a complex world and calls the 
attention to address the complex system forces that sustain 
poverty and poor health [2]. We are far from addressing 
these complex system forces that themselves remain, 
unfortunately, in good health. At the end, we might need 
politics rather than the illusion of independent aid.  
Maria Rubio (mrubioyuste@yahoo.es)
Jose Luis Portero
Madrid, Spain
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Health Development versus Medical 
Relief: Not a Turf Battle
Guy-André Pelouze
Médecins Sans Frontières is a respectable organisation which 
helps people in jeopardy and provides medical relief in 
difﬁ  cult situations all over the world. Despite this recognition 
I must confess I found the last paper of G. Ooms in PLoS 
Medicine [1] to develop highly debatable concepts about 
health, development, and even sustainability. Ooms postulates 
that sustainable intervention creates a bias for development 
agencies to maintain the status quo. 
On the other hand, it could very easily be argued that 
conventional emergency “humanitarian aid” has failed to 
improve health on even a medium-term basis in the last 
four decades. Common sense indicates that populations 
beneﬁ  t more from improvements in wealth, water supply, 
and agriculture than from consuming free goods from 
international aid.
Several studies provide a basis for this conclusion [2]. On 
the contrary, a persistent status quo could result from an 
exclusive humanitarian approach, precluding the necessary 
changes to develop health care.
International agencies say that, based on numerous 
studies, improving health on a medium- or long-term 
basis is a matter of “sustainable” programmes. But what is 
meant by “sustainability”? It seems that Dr. Ooms interprets 
sustainability as durability, a confusion which is obvious 
when one reads the French version of his paper. Durability 
is a plain matter of time; pollution, totalitarian regimes, or 
poverty could as well, unfortunately, meet a single durability 
criterion. This is the main point, if one wants to assess the 
criticism which Ooms aims at development agencies. Their 
main objective is to assess the sustainability of the health 
programmes which means (in French the supportabilité 
and not the durabilité) whether these programs exceed the 
economic, organisational, and ecological possibilities of 
the country and its population. And I recognize that I am 
in keeping with that! To give rice to people who usually 
consume rice is helpful, but next time it will be even more 
helpful to give them the means to grow their own!
Yet the reality is far more complex, something which 
requires that agencies carefully assess the different 
programmes [3]. I must add that such an approach does not 
preclude an increase in annual governments outlays. But 
before increasing expenditure, it is wise to assess whether the 
programmes is working, and for whom. I don’t miss the point 
that sustainable aid is for certain governments synonymous 
with conditional aid, and such difﬁ  culties must not be 
hidden, but every one of us is able to make the distinction 
between the principle and some penny-pinching, restrictive 
policies which can be amended and reversed.
Indeed, the two approaches are complementary. When 
an emergency situation arises, it is obvious that some of 
the critical health issues of the local populations could be 
addressed by emergency international aid. But after a few 
weeks, only structural and political changes (that is, peace, 
convenient water supply, agriculture revival, affordable 
energy, information, free trade, free enterprise through 
microrenting...) are crucial for maintaining health and 
eventually improving it. As a matter of fact it could be a more 
dangerous illusion for these endangered populations to give 
credit to the ideas that Dr. Ooms develops in order to justify 
the spending of more public funds to extend emergency 
humanitarian aid indeﬁ  nitely.  
Guy-André Pelouze (guy-andre.pelouze@ch-perpignan.fr)
St. John Hospital
Perpignan, France
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Spinal Delivery of p38: TNF-alpha 
Inhibitors
Edward Tobinick
The new study by Boyle and colleagues provides important 
data on basic science mechanisms involved in pain and 
inﬂ  ammation [1]. Their data, along with that from 
previous studies, provides further basic scientiﬁ  c evidence 
documenting p38–TNF-alpha interactions, and suggests that 
spinal p38 or spinal TNF-alpha blockade may have clinical 
relevance [1,2]. The present study documents that p38 
activation may be occurring predominantly in microglia. 
The present study, therefore, joins other recent work which 
suggests the importance of p38-glial-TNF-alpha interactions 
in neuroinﬂ  ammation and synaptic signaling [3–6]. This 
increasing evidence may have clinical relevance not only to 
arthritis pain, but also to the pathogenesis of various forms of 
neuropathic pain and Alzheimer disease [1–8].
Because the present study suggests that spinal delivery may 
be more effective than systemic delivery when attempting to 
intervene in spinally-mediated inﬂ  ammatory mechanisms, 
the authors note the potential importance of developing 
compounds that may bypass the blood-brain barrier. The 
present author speculates that the rapid and signiﬁ  cant 
clinical effects noted following perispinal administration 
of etanercept in small pilot studies suggest that perispinal 
administration of p38 inhibitors may also allow these 
compounds to reach the spinal cord and dorsal root ganglia 
in therapeutically effective amounts [7,8]. It is hypothesized 
that this may be possible via passage through the vertebral 
portion of the cerebrospinal venous system, and this may 
explain the efﬁ  cacy of perispinal etanercept in the above 
cited studies [7–9]. Previous studies have documented that 
epidural administration of large molecules may result in 
delivery to the endoneurial space [10]. This evidence, along 
with the basic scientiﬁ  c evidence provided by the present 
study of the potential clinical importance of spinal delivery, 
supports consideration of investigation of this novel route of 
administration.  
Edward Tobinick (etmd@ucla.edu)
Institute for Neurological Research 
Los Angeles, California, United States of America
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